Literature DB >> 18636562

The new tumor suppressor genes ING: genomic structure and status in cancer.

Damien Ythier1, Delphine Larrieu, Christian Brambilla, Elisabeth Brambilla, Rémy Pedeux.   

Abstract

The Inhibitor of Growth 1 (ING1) gene has been identified and characterized as a Type-II tumor suppressor gene (TSG). Subsequently, 4 additional members of the family were identified by homology search. ING proteins contain a nuclear localization sequence (NLS) and a plant homeo domain (PHD) finger motif in their C-terminus. These proteins are involved in numerous signaling pathways especially in 2 tumor suppressor pathways: apoptosis and senescence. In human tumors, several studies have shown that the expression of ING1 is frequently lost or downregulated. It occurs most frequently at the RNA level, and thus epigenetics mechanism could be involved. We summarize the current knowledge on ING proteins functions and their involvement in various signaling pathways. We also review the studies that have investigated the ING protein status in human tumors. The interest of ING proteins as biomarkers and their role in tumor initiation and progression is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18636562     DOI: 10.1002/ijc.23790

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  45 in total

1.  Conserved molecular interactions within the HBO1 acetyltransferase complexes regulate cell proliferation.

Authors:  Nikita Avvakumov; Marie-Eve Lalonde; Nehmé Saksouk; Eric Paquet; Karen C Glass; Anne-Julie Landry; Yannick Doyon; Christelle Cayrou; Geneviève A Robitaille; Darren E Richard; Xiang-Jiao Yang; Tatiana G Kutateladze; Jacques Côté
Journal:  Mol Cell Biol       Date:  2011-12-05       Impact factor: 4.272

Review 2.  The ING family tumor suppressors: from structure to function.

Authors:  Almass-Houd Aguissa-Touré; Ronald P C Wong; Gang Li
Journal:  Cell Mol Life Sci       Date:  2010-08-29       Impact factor: 9.261

3.  Crystallization and preliminary X-ray diffraction analysis of the dimerization domain of the tumour suppressor ING4.

Authors:  Simone Culurgioni; Inés G Muñoz; Alicia Palacios; Pilar Redondo; Francisco J Blanco; Guillermo Montoya
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-04-30

4.  ING3 is required for ATM signaling and DNA repair in response to DNA double strand breaks.

Authors:  Audrey Mouche; Jérôme Archambeau; Charles Ricordel; Laura Chaillot; Nicolas Bigot; Thierry Guillaudeux; Muriel Grenon; Rémy Pedeux
Journal:  Cell Death Differ       Date:  2019-02-25       Impact factor: 15.828

5.  Epigenetic dysregulation in cancer.

Authors:  Andrew G Muntean; Jay L Hess
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

6.  Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy.

Authors:  Aymen Shatnawi; Sridhar A Malkaram; Tamer Fandy; Efrosini Tsouko
Journal:  Mol Cell Biochem       Date:  2019-11-27       Impact factor: 3.396

7.  A novel ING2 isoform, ING2b, synergizes with ING2a to prevent cell cycle arrest and apoptosis.

Authors:  Motoko Unoki; Kensuke Kumamoto; Ana I Robles; Jiang Cheng Shen; Zhi-Ming Zheng; Curtis C Harris
Journal:  FEBS Lett       Date:  2008-10-23       Impact factor: 4.124

8.  Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways.

Authors:  Julieta M Ceruti; María F Ogara; Camino Menéndez; Ignacio Palmero; Eduardo T Cánepa
Journal:  Mol Cell Biochem       Date:  2013-03-04       Impact factor: 3.396

Review 9.  ING proteins as potential anticancer drug targets.

Authors:  M Unoki; K Kumamoto; C C Harris
Journal:  Curr Drug Targets       Date:  2009-05       Impact factor: 3.465

10.  Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy.

Authors:  Mingqing Tang; William Xu; Qizhao Wang; Weidong Xiao; Ruian Xu
Journal:  Curr Genomics       Date:  2009-08       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.